Tools

LEADER 03251nam a2200577 i 4500

001 on1494971767;

005 20250206101227.0;

006 m o d f ;

007 cr |||||||||||;

008 250206s2025 dcua ob f000 0 eng c;

024 8 a| 55-926q| (GPO jacket number);

035 a| (Sirsi) o1494971767;

035 a| (OCoLC)1494971767;

042 a| pcc;

043 a| n-us---;

049 a| XZL4;

074 a| 1028-C (online);

086 0 a| Y 4.W 36:118-FC 19;

088 a| Serial no. 118-FC19 (United States. Congress. House. Committee on Ways and Means);

245 10 a| Examining chronic drug shortages in the United States :b| hearing before the Committee on Ways and Means, House of Representatives, One Hundred Eighteenth Congress, second session, February 6, 2024.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2025.;

300 a| 1 online resource (vi, 328 pages) :b| illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Access ID (govinfo): CHRG-118hhrg55926.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| "Serial no. 118-FC19.";

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Dr. Stephen Schleicher, MD, MBA, Chief Medical Officer, Tennessee Oncology; Eugene Cavacini, Senior Vice President and Chief Operating Officer, McKesson Pharmaceutical Solutions & Services (PSaS); Alan Coukell, BSc, Senior Vice President for Public Policy, Civica Rx; Dr. Stephen Schondelmeyer, PharmD, PhD, Director of the PRIME Institute, University of Minnesota's College of Pharmacy; Dr. Julie Gralow, MD, Chief Medical Officer and Executive Vice President, ASCO; Dr. Jeromie Ballreich, PhD Associate Research Professor, Johns Hopkins Bloomberg School of Public Health.;

518 a| Date of hearing: 2024-02-06.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed February 06, 2025).;

650 0 a| Drug accessibilityz| United States.=| ^A1113855;

650 0 a| Drugsx| Pricesz| United States.=| ^A30023;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

650 0 a| Pharmaceutical policyz| United States.=| ^A139729;

650 7 a| Taxation.2| cgpa;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Ways and Means.t| Examining chronic drug shortages in the United Statesw| (OCoLC)1494971920;

856 40 u| https://purl.fdlp.gov/GPO/gpo2370507| 0;

856 4 z| Address at time of PURL creationu| https://www.govinfo.gov/content/pkg/CHRG-118hhrg55926/pdf/CHRG-118hhrg55926.pdf;

949 a| Click on web addressw| asish| joyner94;

994 a| C0b| GPO;

922 a| BIBCONEWb| 20250206;

922 a| GOVINFOHRGb| 20250206;

922 a| PUBPOLTERMSb| 20250206;

596 a| 1;

998 a| 6563316;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6563316-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 3/19/2025x| EDOCUMENTz| JERESOURCE;

Examining chronic drug shortages in the United States : hearing before the Committee on Ways and Means, House of Representatives, One Hundred Eighteenth Congress, second session, February 6, 2024.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2025.
Description	1 online resource (vi, 328 pages) : illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo237050
Supplemental Content	Address at time of PURL creation
Subjects	Drug accessibility--United States. Drugs--Prices. --United States. Pharmaceutical industry--United States. Pharmaceutical policy--United States.

General note	Access ID (govinfo): CHRG-118hhrg55926.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"Serial no. 118-FC19."
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Dr. Stephen Schleicher, MD, MBA, Chief Medical Officer, Tennessee Oncology; Eugene Cavacini, Senior Vice President and Chief Operating Officer, McKesson Pharmaceutical Solutions & Services (PSaS); Alan Coukell, BSc, Senior Vice President for Public Policy, Civica Rx; Dr. Stephen Schondelmeyer, PharmD, PhD, Director of the PRIME Institute, University of Minnesota's College of Pharmacy; Dr. Julie Gralow, MD, Chief Medical Officer and Executive Vice President, ASCO; Dr. Jeromie Ballreich, PhD Associate Research Professor, Johns Hopkins Bloomberg School of Public Health.
Date/time/place of a event note	Date of hearing: 2024-02-06.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed February 06, 2025).
Issued in other form	Print version: United States. Congress. House. Committee on Ways and Means. Examining chronic drug shortages in the United States
Genre/form	Legislative hearings.
Standard identifier#	55-926 (GPO jacket number)
Technical rpt number	Serial no. 118-FC19 (United States. Congress. House. Committee on Ways and Means)
GPO item number	1028-C (online)
Govt. docs number	Y 4.W 36:118-FC 19

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Online Content https://purl.fdlp.gov/GPO/gpo237050 Address at time of PURL creation	✔ Available

Examining chronic drug shortages in the United States : hearing before the Committee on Ways and Means, House of Representatives, One Hundred Eighteenth Congress, second session, February 6, 2024.

Click here for more information about this title

Availability